Completed PHASE3 INTERVENTIONAL 5-arm NCT00082628

Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients

A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Efficacy of Serostim®, r-hGH in the Treatment and Maintenance of Human Immunodeficiency HIV-Associated Adipose Redistribution Syndrome, or HARS

Sponsor: EMD Serono

Conditions HIV Infections Lipodystrophy

Interventions Placebo Serostim® 2 mg Serostim® 4 mg

Updated 7 times since 2017 Last updated: Oct 2, 2017 Started: May 28, 2004 Primary completion: Sep 28, 2005 Completion: Sep 28, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00082628, this PHASE3 trial focuses on HIV Infections and Lipodystrophy and remains completed. Sponsored by EMD Serono, it has been updated 7 times since 2004, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Aug 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2018 — Aug 2018 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

EMD Serono

Data source: EMD Serono

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albany, United States , Annandale, United States , Atlanta, United States , Austin, United States , Birmingham, United States , Boston, United States , Chicago, United States , Denver, United States , Fort Lauderdale, United States , Indianapolis, United States and 16 more locations